Analysis of IL-12 p40 subunit gene and IFN-gamma G5644A polymorphisms in Idiopathic Pulmonary Fibrosis. 2003

Panagiota Latsi, and Panagiotis Pantelidis, and Dimitris Vassilakis, and Hiroe Sato, and Kenneth I Welsh, and Roland M du Bois
Interstitial Lung Disease Unit, Department of Occupational and Environmental Medicine, Imperial College, National Heart and Lung Institute & Royal Brompton Hospital, London, United Kingdom. pepilats@hotmail.com <pepilats@hotmail.com>

BACKGROUND Genes encoding cytokine mediators are prime candidates for genetic analysis in conditions with T-helper (Th) cell disease driven imbalance. Idiopathic Pulmonary Fibrosis (IPF) is a predominantly Th2 mediated disease associated with a paucity of interferon-gamma (IFN-gamma). The paucity of IFN-gamma may favor the development of progressive fibrosis in IPF. Interleukin-12 (IL-12) plays a key role in inducing IFN-gamma production. The aim of the current study was to assess whether the 1188 (A/C) 3'UTR single nucleotide polymorphism (SNP) in the IL-12 p40 subunit gene which was recently found to be functional and the 5644 (G/A) 3' UTR SNP of the IFN-gamma gene were associated with susceptibility to IPF. METHODS We investigated the allelic distribution in these loci in UK white Caucasoid subjects comprising 73 patients with IPF and 157 healthy controls. The SNPs were determined using the polymerase chain reaction in association with sequence-specific primers incorporating mismatches at the 3'-end. RESULTS Our results showed that these polymorphisms were distributed similarly in the IPF and control groups CONCLUSIONS We conclude that these two potentially important candidate gene single nucleotide polymorphisms are not associated with susceptibility to IPF.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011658 Pulmonary Fibrosis A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death. Alveolitis, Fibrosing,Idiopathic Diffuse Interstitial Pulmonary Fibrosis,Fibroses, Pulmonary,Fibrosis, Pulmonary,Pulmonary Fibroses,Alveolitides, Fibrosing,Fibrosing Alveolitides,Fibrosing Alveolitis
D005260 Female Females
D005787 Gene Frequency The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION. Allele Frequency,Genetic Equilibrium,Equilibrium, Genetic,Allele Frequencies,Frequencies, Allele,Frequencies, Gene,Frequency, Allele,Frequency, Gene,Gene Frequencies
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006147 Guanine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000225 Adenine A purine base and a fundamental unit of ADENINE NUCLEOTIDES. Vitamin B 4,4, Vitamin B,B 4, Vitamin

Related Publications

Panagiota Latsi, and Panagiotis Pantelidis, and Dimitris Vassilakis, and Hiroe Sato, and Kenneth I Welsh, and Roland M du Bois
October 2003, The Journal of experimental medicine,
Panagiota Latsi, and Panagiotis Pantelidis, and Dimitris Vassilakis, and Hiroe Sato, and Kenneth I Welsh, and Roland M du Bois
November 2009, Journal of clinical immunology,
Panagiota Latsi, and Panagiotis Pantelidis, and Dimitris Vassilakis, and Hiroe Sato, and Kenneth I Welsh, and Roland M du Bois
October 1999, Cytokine,
Panagiota Latsi, and Panagiotis Pantelidis, and Dimitris Vassilakis, and Hiroe Sato, and Kenneth I Welsh, and Roland M du Bois
November 2008, The Journal of asthma : official journal of the Association for the Care of Asthma,
Panagiota Latsi, and Panagiotis Pantelidis, and Dimitris Vassilakis, and Hiroe Sato, and Kenneth I Welsh, and Roland M du Bois
December 1997, Cytokines, cellular & molecular therapy,
Panagiota Latsi, and Panagiotis Pantelidis, and Dimitris Vassilakis, and Hiroe Sato, and Kenneth I Welsh, and Roland M du Bois
October 2006, Tissue antigens,
Panagiota Latsi, and Panagiotis Pantelidis, and Dimitris Vassilakis, and Hiroe Sato, and Kenneth I Welsh, and Roland M du Bois
March 2007, Scandinavian journal of immunology,
Panagiota Latsi, and Panagiotis Pantelidis, and Dimitris Vassilakis, and Hiroe Sato, and Kenneth I Welsh, and Roland M du Bois
January 2003, Journal of immunology (Baltimore, Md. : 1950),
Panagiota Latsi, and Panagiotis Pantelidis, and Dimitris Vassilakis, and Hiroe Sato, and Kenneth I Welsh, and Roland M du Bois
January 1994, European cytokine network,
Panagiota Latsi, and Panagiotis Pantelidis, and Dimitris Vassilakis, and Hiroe Sato, and Kenneth I Welsh, and Roland M du Bois
March 2004, Internal medicine journal,
Copied contents to your clipboard!